I can’t imagine how diabetics cope. I’m one of the needle-phobic types that evidently has the perfect ‘I’m gonna pass out’ face. So, those that are hating their insulin shots due to needles have some relief coming in the form of an insulin inhaler. The drug manufacturer, MannKind, is loving life now.
The drug is for patients that require mealtime insulin injections. The FDA is stressing that this is not a replacement for long-acting insulin, so diabetes patients should be aware of that.
Dr. Jean-Marc Guettier of the FDA spoke on how the approval “broadens the options available for delivering mealtime insulin in the overall management of patients with diabetes who require it to control blood sugar levels.”
New treatment options are a must-have for diabetic patients across the United States. The FDA estimates that nearly 26 million Americans live with diabetes. That works out to just over 8 percent of the population. Complications that come from diabetes include vision loss, kidney disease, heart disease, and nerve complications.
For once, the side effects listed don’t sound horrible. You know the commercials are just around the corner, so the most common side effects were low-blood sugar, sore throat and coughing.
One area that the FDA is stepping up is the post-marketing study of the dug. Too many times drugs have been approved only to be black-boxed and removed from the market. The agency wants to study the effectiveness in children, and whether the drug has any connection to lung cancers.
Both Type 1 and 2 diabetics will be able to use the drug, as it showed promise in treating both types of diabetes.
If you watch cable news, prepare for the bombardment of commercials for this product. No word if Liberty Medical will deliver these supplies.